期刊文献+

充血性心力衰竭患者肾素-血管紧张素-醛固酮活性 被引量:1

The changes and significance of renin-angiotensin-aldosterone lactivity in patients with chronic heart failure
下载PDF
导出
摘要 目的探讨充血性心力衰竭(CHF)患者肾素血管紧张素醛固酮系统(RAAS)的活性。方法采用放免法测定收缩压(SBP)<13.33kPa的CHF患者(A组,25例),SBP>13.33kPa的CHF患者(B组,28例)及健康人(对照组,25例)血浆肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)及醛固酮(ALD)水平。结果A组及B组血浆PRA、AngⅡ和ALD均明显高于对照组(P<0.05或0.01);A组血清钠、SBP及脉压/SBP显著低于对照组(P<0.05或0.01),A组血浆PRA、AngⅡ和ALD高于B组(P<0.05或0.01);A组血清钠、SBP及脉压/SBP显著低于B组(P<0.05或0.01)。结论CHF患者体内RAAS活性增高,且SBP<13.33kPa者高于SBP>13.33kPa者。 Objective To explore the renin-angiotensin-aldosterone system (RAAS) activityof patients with congestive heart failure(CHF).Methods 60 patients were divided into two groups according to their systolic blood pressure(SBP):①patients with SBP<13.33kPa (A,n=25); ②patients with SBP>13.33kPa (B,n=28).Normal control gruop incuded 23 health people. Plasmal levels of renin, angiotensin and aldosterone activity(PRA,AngⅡ and ALD) were measured by radio-immunity assay(RIA). Results Plasma levels of PRA, AngⅡ and ALD in A and B groups were significantly higher than those in control group(P<0.05 or 0.01),especially in A group (compared with B group, P< 0.05 or 0.01).A group had lower serum sodium, SBP and pulse pressure/systolic pressure compared with B group(P<0.05 or 0.01). Conclusion RAAS activity is increased in the CHF patients, especially in the patients with SBP lower than 13.33kPa.
出处 《中原医刊》 2005年第11期1-2,共2页 Central Plains Medical Journal
关键词 充血性心力衰竭 肾素 血管紧张素 醛固酮 活性 Heart failure Blood pressure Renin-angiotensin-aldosterone system
  • 相关文献

参考文献7

  • 1Lopes ME, Le Corvoisier P, Tabet JY,et al. Aldosterone and its antagonists in heart failure. Presse Med, 2003,18,32(2):79-87.
  • 2Soberman J, Chafin CC, Weber KT. Aldosterone antagonists in congestive heart failure. Curr Opin Investig Drugs,2002,3(7):1024-1028.
  • 3Palmieri EA, Biondi B, Fazio S. Aldosterone receptor blockade in the management of heart failure. Heart Fail Rev, 2002,7(2):205-219.
  • 4Stevenson L W, Perloff 1 K. The limited reliability of physical signs for the estimation of hemodynamics in chronic heart failure. JAMA,1989,261:884-887.
  • 5Dries DL, Strong MH, Cooper RS,et al. Efficacy of angiotensinconverting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. J Am Coll Cardiol,2002,40(2):311-6.
  • 6Jessup M . Aldosterone blockade and heart failure. N Engl J Med,2003,348(14):1380-1382.
  • 7Pitt B,Zannod F, Remme WJ,et al ,The effect of Spironolactone on morbidity and mortality in patients with severe heart failure,N Engl J Med,1999,341,709-717.

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部